Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.4B | 7.1B | 8.6B | 11.5B |
Cost of revenue | — | 2.0B | 2.2B | 3.5B |
Gross profit | 8.4B | 5.2B | 6.4B | 8.1B |
Operating expense | ||||
Research & development | — | 38.0M | 32.5M | 27.0M |
Selling general and admin | 8.6B | 4.1B | 4.1B | 5.0B |
Other operating expenses | — | 15.5M | 14.9M | 10.0M |
Operating income | 8.4B | -1.8B | 59.1M | 406.4M |
Non operating interest income | ||||
Income | — | 131.7M | 142.5M | 107.5M |
Expense | — | 294.8M | 294.2M | 291.2M |
Other income expense | — | — | — | — |
Pretax income | 565.4M | -1.3B | -93.7M | 3.2B |
Tax provision | 51.0M | -21.4M | 90.7M | 44.4M |
Net income | 514.5M | -1.3B | -184.4M | 3.2B |
Basic EPS | 19.3 | — | -10 | 119 |
Diluted EPS | 19.3 | — | -10 | 79 |
Basic average shares | — | — | 25.6M | 24.9M |
Diluted average shares | — | — | 25.6M | 37.4M |
EBITDA | 8.4B | -1.0B | 394.4M | 2.7B |
Net income from continuing op. | — | -1.3B | -184.4M | 3.2B |
Minority interests | -36.3M | 349.4M | -72.1M | -203.0M |
Preferred stock dividends | — | — | — | — |